Digital Transformation for Case Intake Webinar - Qinecsa

Digital Transformation for Case Intake: The Future of Pharmacovigilance

Webinar: Digital Transformation for Case Intake

The Future of Pharmacovigilance

In today’s rapidly evolving digital landscape, the pharmaceutical industry is embracing cutting-edge technologies to enhance patient safety. Join Qinecsa’s expert, Daniel O’Keefe, where he explores the transformative potential of a digital-first approach to pharmacovigilance.

Learn about the transformative potential of digital case intake, and how you can take your pharmacovigilance processes to the next level with the industry’s latest tech innovations. This webinar delves into how digitalization is reshaping safety monitoring, improving decision-making, and driving efficiencies in pharmacovigilance processes. Learn about the latest trends, the challenges ahead, and how digital transformation will continue to influence patient safety in the future. Gain actionable insights into how industry leaders can stay ahead of the curve in adopting these innovations.

Duration: 30 minutes

Topics & Agenda:

About the speaker

Daniel O’Keeffe

This webinar is led by Qinecsa’s Vice President of Product, Daniel O’Keeffe, who has over 15 years’ experience delivering successful digital solutions in healthcare. Dan leads Qinecsa’s unified adverse event platform, Reportum ®, where he drives excellence and innovation through the latest cutting-edge features.

If you have any questions about our webinar or our services, please feel free to contact us.

Recent Webinars

Balancing technology investments vs benefit: technology enabled services as a route to rapid ROI

Future Ready Pharmacovigilance: When and Why to Outsource

Revolutionizing Literature Screening: Challenges & Innovations

Sign up for the latest Literature Screening webinar! Learn about AI automation and more…

HaloPV 6.0: One unique solution for all your PV system needs

Vigilance Medical Device Guidance – Part 2: Reporting Essentials and Obligations

PreviousNavigating Drug Safety Challenges in Small Pharma and Biotech

NextA Five-Year Roadmap for Technology-led PV Innovation